Classification of Medicines
Recent NZ Gazette Notices Relating to Classification
6 August 2009
9 July 2009
22 June 2009
Gazette notice for 6 August 2009. This notice is to bring into effect an amendment to Schedule 1 of the Medicines Regulations 1984, the Medicines Amendment Regulations 2009. The amendment includes changes recommended by the Medicines Classification Committee at its 41st meeting on 14 May 2009. The amendment came into effect on 7 August 2009.
Gazette notice for 9 July 2009. This notice is to facilitate supply of oseltamivir during the Influenza A (H1N1) Swine Flu pandemic.
Prescription medicines
Oseltamivir; except when sold in a pharmacy between the months of May to September inclusive, or for the duration of the Influenza A (H1N1) Pandemic, by a registered pharmacist who is satisfied that the medicine is for the treatment of a consumer who is resident in New Zealand, is 12 years of age or more, and currently has symptoms of influenza; except when supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic
All previous declarations with respect to the classification of Oseltamivir published in the New Zealand Gazette, 12 February 2009, No. 16, page 405 and Supplement to the New Zealand Gazette, 22 June 2009, No. 91, page 2069, are hereby revoked.
Gazette notice for 22 June 2009. This notice is to facilitate supply of certain antibiotics and anti-viral medicines from community-based assessment centres during the Influenza A (H1N1) swine flu pandemic.
Prescription Medicines
Amoxycillin; except when combined with clavulanic acid in a medicine that is supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic
Cefazolin; except when supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic
Clavulanic acid; except when combined with amoxycillin in a medicine that is supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic
Doxycycline; except when supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic
Flucloxacillin; except when supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic
Oseltamivir; except when sold by a registered pharmacist between the months of May to September inclusive for the treatment of seasonal influenza to a consumer 12 years of age or more presenting in a pharmacy with early symptoms of influenza; except when supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic
Sulfamethoxazole; except when combined with trimethoprim in a medicine that is supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic
Trimethoprim; except when combined with sulfamethoxazole in a medicine that is supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic
Zanamivir; except when supplied from a Community-based Assessment Centre established and operated by a district health board in accordance with a protocol approved by the National Incident Controller for the Influenza A (H1N1) Pandemic